We are live on
!
Find out more
TAM
Tiverton Asset Management Portfolio holdings
AUM
$2.88B
1-Year Est. Return
5.6%
This Fund
S&P 500
This Quarter
Est. Return
+16.23%
1 Year Est. Return
+5.6%
3 Year Est. Return
+61.83%
5 Year Est. Return
+105.31%
10 Year Est. Return
–
AUM
$2.31B
AUM Growth
+$641M
(+38%)
Cap. Flow
+$372M
Cap. Flow
% of AUM
16.15%
Top 10 Holdings %
Top 10 Hldgs %
31.4%
Holding
680
New
190
Increased
323
Reduced
69
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$9.6M |
| 2 |
A.O. Smith
AOS
|
+$7.79M |
| 3 |
JPMorgan Chase
JPM
|
+$7.71M |
| 4 |
Microsoft
MSFT
|
+$6.58M |
| 5 |
Bank of America
BAC
|
+$6.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$7.15M |
| 2 |
Pediatrix Medical
MD
|
+$3.07M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$2.05M |
| 4 |
Wayfair
W
|
+$1.83M |
| 5 |
Arrowhead Research
ARWR
|
+$1.69M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.35% |
| 2 | Healthcare | 15.48% |
| 3 | Consumer Discretionary | 11.83% |
| 4 | Financials | 11.36% |
| 5 | Communication Services | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRA
401
DELISTED
W.R. Grace & Co.
GRA
| $400K | 0.02% |
5,129
-635
| -11% | -$46.8K |
|
402
Insulet
PODD
$9.79B
| $399K | 0.02% |
+4,194
| New | +$359K |
|
403
Regeneron Pharmaceuticals
REGN
$80.8B
| $399K | 0.02% |
+970
| New | +$399K |
|
404
Regions Financial
RF
$26.8B
| $398K | 0.02% |
+28,146
| New | +$431K |
|
405
WEX
WEX
$6.31B
| $396K | 0.02% |
+2,062
| New | +$348K |
|
406
Flex
FLEX
$44.8B
| $394K | 0.02% |
+52,314
| New | +$374K |
|
407
Arrow Electronics
ARW
$10.4B
| $393K | 0.02% |
+5,106
| New | +$392K |
|
408
Exelixis
EXEL
$13.4B
| $391K | 0.02% |
+16,417
| New | +$374K |
|
409
TransUnion
TRU
$15.3B
| $391K | 0.02% |
+5,851
| New | +$362K |
|
410
Penske Automotive Group
PAG
$14.2B
| $390K | 0.02% |
8,735
-535
| -6% | -$23.7K |
|
411
Novartis
NVS
$297B
| $389K | 0.02% |
4,516
| – | – |
|
|
XYZ
412
Block Inc
XYZ
$47.5B
| $389K | 0.02% |
+5,200
| New | +$377K |
|
|
413
Pediatrix Medical
MD
$2.2B
| $387K | 0.02% |
14,245
-91,612
| -87% | -$3.07M |
|
414
JB Hunt Transport Services
JBHT
$25.2B
| $386K | 0.02% |
+3,804
| New | +$394K |
|
415
CubeSmart
CUBE
$9.41B
| $385K | 0.02% |
+12,018
| New | +$365K |
|
416
Crane NXT
CXT
$3.07B
| $383K | 0.02% |
+13,045
| New | +$369K |
|
|
LLL
417
DELISTED
L3 Technologies, Inc.
LLL
| $383K | 0.02% |
+1,858
| New | +$368K |
|
|
BDN
418
Brandywine Realty Trust
BDN
$554M
| $382K | 0.02% |
+24,111
| New | +$364K |
|
419
Emerson Electric
EMR
$88.3B
| $380K | 0.02% |
+5,554
| New | +$365K |
|
420
ITT
ITT
$19.1B
| $380K | 0.02% |
+6,548
| New | +$357K |
|
|
PVTL
421
DELISTED
Pivotal Software, Inc.
PVTL
| $380K | 0.02% |
+18,208
| New | +$356K |
|
422
Xcel Energy
XEL
$48.8B
| $378K | 0.02% |
6,730
+5,127
| +320% | +$273K |
|
|
SRC
423
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $378K | 0.02% |
+9,497
| New | +$362K |
|
424
Hawaiian Electric Industries
HE
$2.14B
| $377K | 0.02% |
+9,258
| New | +$352K |
|
425
Jazz Pharmaceuticals
JAZZ
$16.7B
| $376K | 0.02% |
+2,631
| New | +$343K |
|
Similar funds
TAM
RCM
NA
FCM
STMM
CC
CA
BA
Tiverton Asset Management's Q1 2019 Portfolio in Review
As of Q1 2019, Tiverton Asset Management held 680 positions worth $2.31B, up 38% from $1.66B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Tiverton Asset Management deployed $372M of net new capital in Q1 2019, opening 190 new positions and adding to 323 existing holdings. Its largest new stake was Pfizer: 104,318 shares worth $4.2M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Celgene Corp, an estimated $7.15M trimmed.
- Tiverton Asset Management's largest Q1 2019 buy was Pfizer: 104,318 shares worth $4.2M.
- Tiverton Asset Management added most to Alphabet (Google) Class A in Q1 2019, an estimated $9.6M increase.
- Tiverton Asset Management's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $7.15M.
- Tiverton Asset Management fully exited Bristol-Myers Squibb in Q1 2019, selling an estimated $1.07M.
- Tiverton Asset Management's ten largest holdings make up 31% of its $2.31B portfolio in Q1 2019.
- Tiverton Asset Management opened 190 new positions and closed 28 in Q1 2019.
- Tiverton Asset Management's portfolio value rose 38% quarter-over-quarter to $2.31B.
Based on Tiverton Asset Management's 13F filing for Q1 2019, filed 13 May 2019.